[Synoviorthesis of the knee joint with 32P-chromic phosphate (author's transl)].
32P-CrPO4 in colloid form has been used for radiosynoviorthesis. There were no acute or subacute side reactions observed. The therapy results were equal to those following 90Y colloid application: 60% very good to good results after 6 months. The substance can be kept on stock since it has a relatively long shelf-life. The cost reduction and the simplification of treatment planning have proved to be the most important advantages of 32P-CrPO4.
D002857:Chromium / Q000627:therapeutic use*; D017608:Chromium Compounds; D003102:Colloids; D006801:Humans; D008875:Middle Aged; D010710:Phosphates / Q000627:therapeutic use*; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use*; D013585:Synovitis / Q000188:drug therapy*
D017608:Chromium Compounds; D003102:Colloids; D010710:Phosphates; D010761:Phosphorus Radioisotopes; D002857:Chromium; C509369:chromic phosphate
Die Synoviorthese des Kniegelenkes mit 32P-Chromphosphat.